Recordati Industria Chimica e Farmaceutica SPA Financial Overview
Recordati Industria Chimica e Farmaceutica SPA's market cap is currently €10.05B. The company's EPS TTM is €0.79; its P/E ratio is 24.79; and it has a dividend yield of 2.67%. Recordati Industria Chimica e Farmaceutica SPA is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.